1,110 results on '"Takehara, Kazuhiko"'
Search Results
302. Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases
303. Implications of Popliteal Lymph Node Detected by Sentinel Lymph Node Biopsy
304. Inhibitory Role of CD19 in the Progression of Experimental Autoimmune Encephalomyelitis by Regulating Cytokine Response
305. L-selectin and intercellular adhesion molecule-1 regulate the development of Concanavalin A-induced liver injury
306. Lymphatic Mapping and Sentinel Lymph Node Biopsy for Staging of Aggressive Digital Papillary Adenocarcinoma
307. Myocardial Damages in Systemic Sclerosis Detected by Gated Myocardial Perfusion SPECT and Sympathetic Imaging
308. Quantification of Human Tissue Kallikreins in the Stratum Corneum: Dependence on Age and Gender
309. Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patients with dermatomyositis
310. Drug-Induced Hypersensitivity Syndrome Associated with Human Herpesvirus 6 and Cytomegalovirus Reactivation
311. Clinical significance of serum levels of soluble intercellular adhesion molecule-1 and soluble L-selectin in malignant melanoma
312. Abnormal Natural Killer Cell Function in Systemic Sclerosis: Altered Cytokine Production and Defective Killing Activity
313. Reactive hemophagocytic syndrome in a patient with polyarteritis nodosa associated with Epstein–Barr virus reactivation
314. Anti-DNA topoisomerase II α autoantibodies in Japanese patients with systemic sclerosis
315. Pathogenesis of systemic sclerosis: Altered B cell function is the key linking systemic autoimmunity and tissue fibrosis
316. Successful treatment with sildenafil in systemic sclerosis patients with isolated pulmonary arterial hypertension: two case reports
317. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis
318. Implications of Popliteal Lymph Node Detected by Sentinel Lymph Node Biopsy
319. A statistical study of 55 patients with extramammary Paget's disease
320. Elevated serum BAFF levels in patients with systemic sclerosis: Enhanced BAFF signaling in systemic sclerosis B lymphocytes
321. Connective tissue growth factor causes persistent pro?2(I) collagen gene expression induced by transforming growth factor-? in a mouse fibrosis model
322. Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: A sensitive indicator of active pulmonary fibrosis
323. Molecular diagnosis of basal cell carcinoma and other basaloid cell neoplasms of the skin by the quantification of Gli1 transcript levels
324. Role of C-C chemokine receptors?1 and?5 and CCL3/macrophage inflammatory protein-1? in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production
325. Association of a functionalCD19 polymorphism with susceptibility to systemic sclerosis
326. Management of Squamous Cell Carcinoma in a Patient with Recessive-Type Epidermolysis Bullosa Dystrophica
327. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis
328. Sentinel Lymph Node Biopsy in Patients with Extramammary Pagetʼs Disease
329. Elevated expression of CD23 on peripheral blood B lymphocytes from patients with bullous pemphigoid: correlation with increased serum IgE
330. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis
331. A case of scleroderma spectrum disorder with anticentriole antibody and pulmonary hypertension
332. Augmented production of transforming growth factor-β by cultured peripheral blood mononuclear cells from patients with systemic sclerosis
333. P-selectin glycoprotein ligand-1 is required for the development of cutaneous vasculitis induced by immune complex deposition
334. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: Possible contribution to skin inflammation
335. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis
336. Improvement of skin sclerosis after occurrence of anticentromere antibody in a patient with diffuse cutaneous systemic sclerosis
337. The diagnostic value of oesophageal transit scintigraphy for evaluating the severity of oesophageal complications in systemic sclerosis
338. Novel Autoantibody to Cu/Zn Superoxide Dismutase in Patients with Localized Scleroderma
339. Transforming growth factor‐β signaling is differentially inhibited by Smad2D450E and Smad3D407E
340. Anti-DNA topoisomerase II? autoantibodies in localized scleroderma
341. Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice
342. Ultraviolet Light Exposure Suppresses Contact Hypersensitivity by Abrogating Endothelial Intercellular Adhesion Molecule-1 Up-Regulation at the Elicitation Site
343. Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells
344. Expression and Localization of Tissue Kallikrein mRNAs in Human Epidermis and Appendages
345. Ligand-dependent Inhibition of B16 Melanoma Cell Migration and Invasion via Endogenous S1P2 G Protein-coupled Receptor
346. Skin Manifestations in Rheumatologic Disorders.
347. Relative Contributions of Selectins and Intercellular Adhesion Molecule-1 to Tissue Injury Induced by Immune Complex Deposition
348. L-Selectin or ICAM-1 Deficiency Reduces an Immediate-Type Hypersensitivity Response by Preventing Mast Cell Recruitment in Repeated Elicitation of Contact Hypersensitivity
349. Function Blocking Autoantibodies Against Matrix Metalloproteinase-1 in Patients with Systemic Sclerosis
350. A Case of Lepromatous Type Hansen's Disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.